Telesis Bio, Inc. (TBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.0510
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
Telesis Bio Employees
Telesis Bio had 147 employees as of December 31, 2023. The number of employees decreased by 96 or -39.51% compared to the previous year.
Employees
147
Change (1Y)
-96
Growth (1Y)
-39.51%
Revenue / Employee
$436,769
Profits / Employee
-$1,228,872
Market Cap
91.89K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 147 | -96 | -39.51% |
| Dec 31, 2022 | 243 | 7 | 2.97% |
| Dec 31, 2021 | 236 | 145 | 159.34% |
| Dec 31, 2020 | 91 | - | - |
Telesis Bio News
- 1 year ago - Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis - GlobeNewsWire
- 1 year ago - Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market - GlobeNewsWire
- 1 year ago - Telesis Bio Reports Second Quarter and First Half 2024 Financial Results - GlobeNewsWire
- 2 years ago - Telesis Bio Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 years ago - Telesis Bio Announces Reverse Stock Split - GlobeNewsWire
- 2 years ago - Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership - GlobeNewsWire
- 2 years ago - Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 years ago - Telesis Bio Transcript: TD Cowen 44th Annual Health Care Conference 2024 - Transcripts